Federation des caisses Desjardins du Quebec’s Legend Biotech LEGN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.4K	Buy	1,605 +1,500	+1,429%	+$40.5K	﹤0.01%	1948
2026 Q1	$1.9K	Sell	105 -150	-59%	-$2.86K	﹤0.01%	2683
2025 Q4	$5.54K	Buy	255 +2	+0.8%	+$57	﹤0.01%	2425
2025 Q3	$8.25K	Hold	253	–	–	﹤0.01%	2318
2025 Q2	$8.98K	Sell	253 -199	-44%	-$6.45K	﹤0.01%	2073
2025 Q1	$15.3K	Sell	452 -305	-40%	-$10.9K	﹤0.01%	1818
2024 Q4	$24.6K	Hold	757	–	–	﹤0.01%	1612
2024 Q3	$36.9K	Buy	757 +103	+16%	+$5.49K	﹤0.01%	1484
2024 Q2	$29K	Buy	+654	New	+$30.2K	﹤0.01%	1518

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's LEGN Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Legend Biotech (LEGN) stake by 1,429% in Q2 2026, buying an estimated $40.5K and bringing the position to 1,605 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Federation des caisses Desjardins du Quebec first reported a position in LEGN in Q2 2024 and has held it in 9 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Federation des caisses Desjardins du Quebec held 1,605 shares of Legend Biotech worth $46.4K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 1,500 Legend Biotech shares in Q2 2026, an estimated $40.5K.
Legend Biotech made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1948 holding.
Federation des caisses Desjardins du Quebec first reported a position in Legend Biotech in Q2 2024 and has held it in 9 quarters since.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.